New Real-World study tracks Add-On seizure drug effectiveness
NCT ID NCT05867160
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study follows 300 adults with focal onset seizures who are starting an additional anti-seizure medicine (ASM) alongside their current treatment. Researchers will track changes in seizure frequency and quality of life over 12 months in real-world conditions. The goal is to understand how well the add-on therapy works outside of controlled clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilettologia Clinica e Sperimentale - Centro di Medicina del Sonno
Milan, 20133, Italy
Conditions
Explore the condition pages connected to this study.